FDA Inspection 661210 — Kaysersberg Pharmaceuticals SAS

Kaysersberg Pharmaceuticals SAS — FEI 3002806288

The FDA completed an inspection of Kaysersberg Pharmaceuticals SAS on Apr 19, 2010 in Kaysersberg. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Apr 19, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Kaysersberg (France)